South Korea Viral Clearance Market Size, Regional Trends and Opportunities, Revenue Analysis, For 2031

 

Viral detection and clearance are performed to demonstrate the clearance of viruses associated with a process. Viral clearance services are useful for industry before biologics are brought to market.

Explore More Insights@ https://www.alliedmarketresearch.com/request-sample/17475

No test exists to detect all viruses at once, so a minimum level virus test is used for diagnosis. Some methods measure markers of infection, giving results days after infection. Therefore, ensuring that a product is free from viral contamination depends on ensuring that the process can inactivate or remove viruses as well as testing for their presence. Such an approach is the only way to ensure that biopharmaceuticals are free from viral contamination and safe for human consumption. It is also important to identify which viruses can contaminate the product and enter its manufacturing process.

North America held the largest market share in the viral clearance testing industry in 2021 and is expected to maintain its dominance over the forecast period. This is mainly due to the increase in demand for biopharmaceuticals and advanced technologies for the purification of recombinant proteins produced by animal cell cultures for the production of high-value products of modern biotechnology.

According to a new report published by Allied Market Research, titled “Viral Clearance Market”, the Viral Clearance market was valued at $425.93 Mn in 2021 and is projected to grow at a CAGR of 8.6% from 2022 to reach $977.8 Million by 2031.

Key Findings Of The Study

• The viral removal segment held 59.39% share in the global market in 2021.
• Recombinant proteins segment held the largest market share in 2021, and is expected to remain dominant throughout the forecast period.
• Pharmaceutical and biotechnology companies segment held the largest market share in 2021, and is expected to remain dominant throughout the forecast period.
• North America is expected to experience the highest market share during the forecast period. This was attributed to biopharmaceutical and upsurge in demand for advanced technologies in the purification of recombinant proteins produced by animal cell cultures to create high-value products of modern biotechnology.